Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2004 2
2006 1
2009 1
2012 1
2014 1
2016 1
2018 1
2021 3
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
Cohen D, Izak M, Stoyanov E, Mandelboim M, Perlman S, Amir Y, Goren S, Bialik A, Kliker L, Atari N, Yshai R, Zaide Y, Marcus H, Madar-Balakirski N, Israely T, Paran N, Zimhony O, Shinar E, Maor Y, Muhsen K. Cohen D, et al. Among authors: marcus h. Int J Infect Dis. 2023 Jul;132:72-79. doi: 10.1016/j.ijid.2023.04.395. Epub 2023 Apr 16. Int J Infect Dis. 2023. PMID: 37072052 Free PMC article.
Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera.
Yahalom-Ronen Y, Erez N, Fisher M, Tamir H, Politi B, Achdout H, Melamed S, Glinert I, Weiss S, Cohen-Gihon I, Israeli O, Izak M, Mandelboim M, Caraco Y, Madar-Balakirski N, Mechaly A, Shinar E, Zichel R, Cohen D, Beth-Din A, Zvi A, Marcus H, Israely T, Paran N. Yahalom-Ronen Y, et al. Among authors: marcus h. Vaccines (Basel). 2022 Feb 14;10(2):291. doi: 10.3390/vaccines10020291. Vaccines (Basel). 2022. PMID: 35214749 Free PMC article.
Fc-Independent Protection from SARS-CoV-2 Infection by Recombinant Human Monoclonal Antibodies.
Noy-Porat T, Edri A, Alcalay R, Makdasi E, Gur D, Aftalion M, Evgy Y, Beth-Din A, Levy Y, Epstein E, Radinsky O, Zauberman A, Lazar S, Yitzhaki S, Marcus H, Porgador A, Rosenfeld R, Mazor O. Noy-Porat T, et al. Among authors: marcus h. Antibodies (Basel). 2021 Nov 8;10(4):45. doi: 10.3390/antib10040045. Antibodies (Basel). 2021. PMID: 34842604 Free PMC article.
Thermophilic Filamentous Fungus C1-Cell-Cloned SARS-CoV-2-Spike-RBD-Subunit-Vaccine Adjuvanted with Aldydrogel®85 Protects K18-hACE2 Mice against Lethal Virus Challenge.
Nechooshtan R, Ehrlich S, Vitikainen M, Makovitzki A, Dor E, Marcus H, Hefetz I, Pitel S, Wiebe M, Huuskonen A, Cherry L, Lupu E, Sapir Y, Holtzman T, Aftalion M, Gur D, Tamir H, Yahalom-Ronen Y, Ramot Y, Kronfeld N, Zarling D, Vallerga A, Tchelet R, Nyska A, Saloheimo M, Emalfarb M, Ophir Y. Nechooshtan R, et al. Among authors: marcus h. Vaccines (Basel). 2022 Dec 11;10(12):2119. doi: 10.3390/vaccines10122119. Vaccines (Basel). 2022. PMID: 36560529 Free PMC article.
Preliminary nonclinical safety and immunogenicity of an rVSV-ΔG-SARS-CoV-2-S vaccine in mice, hamsters, rabbits and pigs.
Madar-Balakirski N, Rosner A, Melamed S, Politi B, Steiner M, Tamir H, Yahalom-Ronen Y, Bar-David E, Ben-Shmuel A, Sittner A, Glinert I, Weiss S, Bar-Haim E, Cohen H, Elia U, Achdout H, Erez N, Rotem S, Lazar S, Nyska A, Yitzhaki S, Beth-Din A, Levy H, Paran N, Israely T, Marcus H. Madar-Balakirski N, et al. Among authors: marcus h. Arch Toxicol. 2022 Mar;96(3):859-875. doi: 10.1007/s00204-021-03214-w. Epub 2022 Jan 15. Arch Toxicol. 2022. PMID: 35032184 Free PMC article.
rVSV-ΔG-SARS-CoV-2-S vaccine: repeated intramuscular (IM) toxicity, local tolerance, immunogenicity and biodistribution study in NZW rabbits.
Rosner A, Steiner M, Melamed S, Politi B, Vitner E, Tamir H, Achdout H, Cherry L, Avraham R, Yahalom-Ronen Y, Levy H, Beth-Din A, Stein D, Mechaly A, Fisher M, Fatelevich E, Weiss S, Kronfeld N, Madar-Shapiro L, Nyska A, Yitzhaki S, Paran N, Israely T, Marcus H, Madar-Balakirski N. Rosner A, et al. Among authors: marcus h. Arch Toxicol. 2022 Aug;96(8):2329-2339. doi: 10.1007/s00204-022-03302-5. Epub 2022 May 17. Arch Toxicol. 2022. PMID: 35577986 Free PMC article.
Serologic Evidence of Ebolavirus Infection in a Population With No History of Outbreaks in the Democratic Republic of the Congo.
Mulangu S, Alfonso VH, Hoff NA, Doshi RH, Mulembakani P, Kisalu NK, Okitolonda-Wemakoy E, Kebela BI, Marcus H, Shiloach J, Phue JN, Wright LL, Muyembe-Tamfum JJ, Sullivan NJ, Rimoin AW. Mulangu S, et al. Among authors: marcus h. J Infect Dis. 2018 Jan 30;217(4):529-537. doi: 10.1093/infdis/jix619. J Infect Dis. 2018. PMID: 29329455 Free PMC article.
Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody.
Corti D, Misasi J, Mulangu S, Stanley DA, Kanekiyo M, Wollen S, Ploquin A, Doria-Rose NA, Staupe RP, Bailey M, Shi W, Choe M, Marcus H, Thompson EA, Cagigi A, Silacci C, Fernandez-Rodriguez B, Perez L, Sallusto F, Vanzetta F, Agatic G, Cameroni E, Kisalu N, Gordon I, Ledgerwood JE, Mascola JR, Graham BS, Muyembe-Tamfun JJ, Trefry JC, Lanzavecchia A, Sullivan NJ. Corti D, et al. Among authors: marcus h. Science. 2016 Mar 18;351(6279):1339-42. doi: 10.1126/science.aad5224. Epub 2016 Feb 25. Science. 2016. PMID: 26917593
20 results